🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSwitzerland BAG coverage — anyone have experience? Page 10

Switzerland BAG coverage — anyone have experience?

hank_denver Mon, Jul 22, 2024 at 6:40 AM 47 replies 3,019 viewsPage 10 of 10
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Oct 27, 2024 at 12:03 PM#46

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

5 5FitDadDave, RunnerRach, TrialNerd_Beth and 2 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Oct 31, 2024 at 12:46 AM#47

OP back with an update, since a thread like this is useless without one.

Closing this out. What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and worth saying anyway.

Last edited: Oct 31, 2024 at 4:46 AM
4 4raj_cambridge, ingrid_STO, pete_nash and 1 other
Reply Quote Save Share Report
emma_london
Member
312
1,456
Oct 2024
London, UK
Nov 3, 2024 at 1:31 PM#48
Dr.AddMedPHL said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Adding the part of the answer the thread has not reached. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

3 3TomFromTexas, mike.trainer_LA, sarah_nash92
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Nov 7, 2024 at 2:18 AM#49

Old thread, but it comes up first when you search for this, so it is worth updating. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Nov 7, 2024 at 7:18 AM
2 2DataDave, Dr.GutHealth
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Nov 10, 2024 at 3:07 PM#50

One thing that is still open after Dr.AddMedPHL’s answer:

Was that from a primary source or from a summary of one?

30 5tyler_CSCS, VanRx_Mike, steve_okc and 27 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register